une absence de réponse clinique et/ou radiologique associée le plus souvent à une mauvaise tolérance hématologique des chimiothérapies conventionnelles par voie intraveineuse. L'état général des patients était bon avant l'initiation de la chimiothérapie intra-artérielle. La tolérance de la chimiothérapie intra-artérielle a été globalement bonne sur le plan hématologique (cf. Tableau XI) Un patient a présenté une aplasie et un autre une toxicité cardiaque, aucun n'a gardé de séquelles. La procédure en elle-même n'a pas engendré de toxicité, preuve qu'elle est bien maitrisée ,
Tumeurs intracr??niennes de l'adulte, EMC - Trait?? de m??decine AKOS, vol.5, issue.2, pp.5-1001, 2010. ,
DOI : 10.1016/S1634-6939(10)52309-3
Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique, pp.159-75, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00338335
Radiodiagnostic -Squelette normal -Neuroradiologie-Appareil locomoteur, pp.31-660, 2006. ,
Revue neurologique, Mai, vol.165, pp.863-74, 2009. ,
Nonpermeable and permeable vessels of the brain, NIDA Res monogr, vol.120, pp.87-107, 1992. ,
DOI : 10.1037/e496142006-009
Junctional complexes of the blood???brain barrier: permeability changes in neuroinflammation, Progress in Neurobiology, vol.68, issue.5, pp.311-334, 2002. ,
DOI : 10.1016/S0301-0082(02)00128-4
Recent studies on the structure and pathology of basement membranes, The Journal of Pathology, vol.797, issue.4 ,
DOI : 10.1016/0304-4165(84)90384-2
Agrin and microvascular damage in Alzheimer???s disease, Neurobiology of Aging, vol.21, issue.2, pp.349-55, 2000. ,
DOI : 10.1016/S0197-4580(00)00121-4
SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier, Nature Medicine, vol.7, issue.7, pp.900-906, 2003. ,
DOI : 10.1038/86507
Angiotensin II Controls Occludin Function and Is Required for Blood Brain Barrier Maintenance: Relevance to Multiple Sclerosis, Journal of Neuroscience, vol.27, issue.34, pp.9032-9074, 2007. ,
DOI : 10.1523/JNEUROSCI.2088-07.2007
Tight junctions of the blood???brain barrier, Vascular Pharmacology, vol.38, issue.6, pp.323-360, 2002. ,
DOI : 10.1016/S1537-1891(02)00200-8
Drug resistance in brain diseases and the role of drug efflux transporters, Nature Reviews Neuroscience, vol.5, issue.Suppl. 1, pp.591-602, 2005. ,
DOI : 10.2174/1389200043489199
Potential role of ABC transporters as a detoxification system at the blood- CSF barrier, Adv Drug Deliv Rev, vol.56, pp.1793-809, 2004. ,
Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems, NeuroRX, vol.1359, issue.1193, pp.54-62, 2005. ,
DOI : 10.1016/S0167-4889(97)00096-7
Subcellular localization of transporters along the rat blood???brain barrier and blood???cerebral-spinal fluid barrier by in vivo biotinylation, Neuroscience, vol.155, issue.2 ,
DOI : 10.1016/j.neuroscience.2008.06.015
Glioblastome multiforme: evidence-based approach to therapy. Expert rev anticancer, pp.23-30, 2007. ,
Testing of a hypothesis for osmotic opening of the bloodbrain barrier, Am J Physiol, vol.223, pp.323-354, 1972. ,
La barrière hémato-encéphalique : un facteur clé en Neuro-oncologie, Rev Neurol. Mai, vol.160, issue.5, pp.523-555, 2004. ,
Therapeutic manipulation of the blood-brain barrier. Neurobaseneurosurgery . First edition, Medlink CD-ROM, 2003. ,
Enhanced delivery of carboplatin into brain tumours with intravenous CereportTM (RMP-7): dramatic differences and insight gained from dosing parameters, British Journal of Cancer, vol.80, issue.7, pp.964-70, 1999. ,
DOI : 10.1038/sj.bjc.6690450
Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children???s Oncology Group, Cancer Chemotherapy and Pharmacology, vol.48, issue.3, pp.343-350, 2006. ,
DOI : 10.1007/s00280-005-0172-7
A randomised, double-blind, placebocontrolled , phase 2 study of RMP-7 in combinaison with carboplatin administered intravenously for the treatment of malignant glioma. Neuro-oncol, pp.96-103, 2003. ,
The blood-brain barrier and cancer. Clin Cancer Res, 2007. ,
Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo, Journal of Clinical Investigation, vol.110, issue.9, pp.1309-1327, 2002. ,
DOI : 10.1172/JCI0215451
Mechanisms of tumor cell invasion and angiogenesis in the central nervous system, front Biosci, vol.8, pp.289-304, 20031. ,
Implication de la barrière hémato-encéphalique dans la physiopathologie des maladies neurologiques: Partie II. Revue neurol, pp.1010-1032, 2009. ,
DOI : 10.1016/j.neurol.2009.04.013
Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme, Acta Neuropathol, 2003. ,
Occludin expression in microvessels of neoplastic and non-neoplastic human brain, Neuropathology and Applied Neurobiology, vol.129, issue.5, pp.384-95, 2001. ,
DOI : 10.1083/jcb.120.2.477
The effect of P-glycoprotein on paclitaxel brain and brain tumor distribution in mice. Cancer research, pp.5114-5121, 2003. ,
Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo, Journal of Clinical Investigation, vol.110, issue.9, pp.1309-1318, 2002. ,
DOI : 10.1172/JCI0215451
Pharmacocinétique du cisplatine : comparaison expérimentale de la voie intra-artérielle hépatique et de la voie veineuse systémique chez le porc. Gastroenterologie clinique et biologique, Mars, vol.33, issue.HS1, p.153, 2009. ,
DOI : 10.1016/s0399-8320(09)72901-x
Differential permeability of a human brain tumor xenograft in the nude rat: impact of tumor size and method of administration on optimizing delivery of biologicaly diverse agents. Clin Cancer Res, pp.1549-55, 1998. ,
A review of hyperosmotic blood-brain barrier disruption in seven experimental brain tumors models, Pathophysiology of the blood-brain barrier, pp.197-220, 1990. ,
Differential Permeability of Human Brain Tumor Xenograft in the nude rat: Impact of size tumor and Method of Administration on optmizing delivery of biologically diverse agent. Clinical Cancer Research, pp.1549-55, 1998. ,
Distribution of radiolabeled 1-(4-Amino-2-methyl-5- pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride in rat brain tumor: intraarterial versus intravenous administration, Cancer Res, vol.7, issue.8, pp.2123-2151, 1987. ,
Comparison of intravenous versus intracarotid therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea in a rat brain tumor model, Cancer Res ,
Selective opening of the blood tumor barrier by a nitric oxide donor and long-term survival in rats with C6 gliomas, J. neurosurg, 2003. ,
Intraarterial chemotherapy and osmotic bloodbrain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system. Cancer, Feb, vol.1, issue.1123, pp.581-589, 2008. ,
Enhanced Chemotherapy delivery by intraarterial infusion and blood brain barrier disruption in malignant brain tumors The Sherbrook Experience. Cancer, Jun, vol.15103, issue.12, pp.20606-20621, 2005. ,
Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis, Cancer, vol.8, issue.4 ,
DOI : 10.1001/archneur.1996.00550080140022
A phase I study of intracarotid Artery infusion of cisdiamminedichloroplatinum(II ) in patients with recurrent malignant intracerebral tumors ,
Intra-arterial carboplatin and intraveinous etoposide for the treatment of metastatic brain tumors, Journal of Neuro-Oncology, vol.61, issue.1, pp.35-44, 2003. ,
DOI : 10.1023/A:1021218207015
Effect of 1-(4-amino-2-methyl-5-pyrimidinyl), p.3 ,
Effect of ACNU on experimental brain tumor, Cancer Res, vol.39, issue.7, pp.2687-90, 1979. ,
Adjuvant intraarterial chemotherapy with nimustine in the management of World Health Organization Grade IV gliomas of the brain, pp.1984-94, 1989. ,
Prevalence and rupture rate of cerebral aneuvrisms discovered during intra-arterial chemotherapy of brain tumors, AJNR Am J ,
Epidemiology of aneurysmal subarachnoid hemorrhage, Neuroimaging Clin N ,
Intracranial Aneurysms, New England Journal of Medicine, vol.336, issue.1, pp.28-40, 1997. ,
DOI : 10.1056/NEJM199701023360106
Trends in survival from primary central nervous system lymphoma, 1975-1999, Cancer, vol.103, issue.11, pp.2466-72, 2005. ,
DOI : 10.7326/0003-4819-129-12-199812150-00005